OpenFilings
Inmune Bio, Inc.
Form
8-K
Report Period
2025-06-10
Date Filed
2025-06-10
Time Filed
16:00:16
Document Analysis
Natural Language Processing
Recognized Type
Unidentified
Defined Term Format
Underlined
Italicized
Bold
Exhibits
CURRENT REPORT
SECOND AMENDED AND RESTATED INMUNE BIO INC. 2021 STOCK INCENTIVE PLAN
PRESS RELEASE, DATED JUNE 10, 2025
Filing on SEC Edgar